Crown Energy AB (publ) announces that its subsidiary Accyourate Group S.p.A. has entered into an initial distribution agreement in Albania with local partner 2A-Pharma shpk. The agreement is intended to support a structured entry into the Albanian market for Accyourate’s wearable ECG monitoring devices, smart garments and associated cloud-based data analysis and management services, with an initial commercial focus on private healthcare.
Accyourate’s platform is designed to enable continuous monitoring of key physiological signals, including ECG, heart rate, breathing patterns, temperature and movement, in real-world conditions. Crown believes this makes the offering relevant not only for private healthcare, but also for adjacent areas such as sport, occupational health, prevention and safety.
The opportunity has been identified and developed through Accyourate’s network and market familiarity in Albania, and builds on earlier project activity together with the Albanian Olympic Committee. The first route to market is expected to be through private healthcare providers, selected clinics and other institutional users, creating a practical foothold from which broader opportunities can be pursued over time, including in prevention and screening-related settings.
“Albania gives us a focused and practical opportunity to begin building commercial traction for Accyourate. We already know the market from earlier activity, and through local relationships and the right partner structure we see a credible route into private healthcare. At the same time, the technology has relevance far beyond traditional clinic use, including sport, prevention and occupational health. This is the kind of step-by-step commercial development we want to build for Accyourate,” says Yoav Ben-Eli, CEO of Crown Energy.